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Labor Management Protocol for Parturients on Buprenorphine 
Erik Sanders BSN, RN 
Executive Summary 
Introduction of the Problem 
 Opioid dependence in the US has reached epidemic levels (Reddy, Davis, Ren & Greene, 
2017). Opioid dependence during pregnancy may lead to negative outcomes for both the 
parturient and the fetus. Women with known opioid dependence are often prescribed drugs such 
as methadone, or more recently, buprenorphine. Buprenorphine, an opioid, is a partial mu 
receptor agonist prescribed by providers as a form of medication assisted therapy (MAT) for 
opioid addiction and chronic opioid use (Reddy et al., 2017). The use of buprenorphine within 
parturients is a relatively new practice and anesthesia providers are encountering difficulties in 
managing this population during the peripartum period. The lack of a comprehensive, 
standardized approach for pain management during the peripartum period for the parturient on 
buprenorphine therapy has created many challenges for anesthesia providers. Given the 
increasing number of opioid dependent parturients, the creation of effective pain management 
regimen for this group is a priority. A Midwestern tertiary care center does not have a protocol 
for the care of parturients on buprenorphine therapy, and anesthesia providers and obstetricians 
desire the development of an organized plan for the care of this population. 
Literature Review 
 The goal of pain management in this patient population is to effectively manage the 
intrapartum period to improve patient satisfaction and outcomes, reduce the overall cost of their 
health care, decrease the length of stay, and promote maternal-child bonding postpartum. 
Women are encouraged to continue their MAT while pregnant. Abruptly stopping treatment can 
lead to ill outcomes, including intractable pain and opioid withdrawal symptoms (Souzdalnitski 
& Snegovskikh, 2014). Pain management strategies should be formulated based upon the clinical 
and psychological presentation of the parturient with clear and realistic goals (Pan & Zakowski, 
2017). 
 The use of regional anesthesia during the anesthetic period is an acceptable source of 
analgesia and is preferable to systemic opioid use (Pan & Zakowski, 2017; Park, Meltzer-Brody 
& Suzuki, 2012). Alto & O’Connor (2011) noted that non-opioid analgesics may be sufficient for 
post-vaginal delivery pain, but opioids should be available if the pain to becomes more severe.  
Patient controlled analgesia (PCA) is an option for the acute management of breakthrough pain 
in this population after a cesarean (Jones et al., 2008; Meyer et al., 2010; Reddy et al., 2017). 
There are, however, certain drugs which should be avoided when providing analgesia for 
parturient taking buprenorphine. Drugs such as nalbuphine and butorphanol are mixed opioid 
agonist-antagonist drugs. Thus, a parturient who receives one of those drugs may develop 
withdrawal symptoms related to the opioid antagonist component of the medication (Jones, et al., 
2008; Reddy et al., 2017). 
Project Methods 
 The purpose of this project was to create a labor pain management protocol for 
parturients on buprenorphine at a Midwestern tertiary care center. The main goal of the project 
was to perform a thorough literature review related to the peripartum management of women 
taking buprenorphine and subsequently disseminate those findings in the form of a PowerPoint 
presentation to primary stakeholders in the anesthesia and obstetrics departments. Prior to 
implementation, the project’s proposal was submitted for evaluation and deemed exempt by 
Southern Illinois University Edwardsville’s Institutional Review Board (IRB). 
Evaluation 
 The primary outcome measured for this project was the multidisciplinary team’s 
knowledge of buprenorphine after the presentation. A true/false questionnaire aimed at 
evaluating the author’s effectiveness in teaching the team members about buprenorphine was 
distributed at the conclusion of the presentation. Of the staff members in attendance, six returned 
surveys. Several members of a typical parturient’s care team were represented, including two 
nurse anesthetists, two obstetrical nurses, a pharmacist, as well as a maternal/fetal medicine 
physician. All respondents correctly identified that buprenorphine is an opioid agonist-
antagonist. Only half of the participants correctly identified that Suboxone was not the correct 
trade name for buprenorphine (Subutex). All participants correctly noted that ACOG 
recommends continuing buprenorphine throughout the peripartum period. The majority of 
respondents (5/6; 89%), recognized that neonatal abstinence syndrome is a potential 
complication of buprenorphine therapy. All participants understood that parturients on 
buprenorphine may receive neuraxial analgesia. All respondents correctly indicated that 
parturients on buprenorphine may exhibit hyperalgesia and also have a 47% increase in opioid 
requirements post cesarean-section. Finally, all respondents noted that Nubain and Stadol were 
not good analgesic options for this population. 
 Included at the conclusion of the questionnaire was a five-point Likert scale gauging the 
degree of support for a labor management protocol at the host facility. The mean score was a 
4.67/5, indicating strong support and a recognized need for a labor management protocol for 
parturients on buprenorphine therapy. 
 One major limitation faced by this project was the small sample size. The number of 
participants was directly related to high workload in the operating room and labor unit the day of 
the presentation. As such, the results of the questionnaire may not be generalizable to a larger 
number of respondents due to a small sample size. Another limitation of the project is the lack of 
evidence available from the literature review. Few studies exist detailing pain management for 
parturients on buprenorphine during the peripartum period and no example pain management 
protocols for the parturient population were discovered during the literature search.  
Impact on Practice 
 Results of the survey indicated that the educational presentation created a strong level of 
support for the introduction of a pain management protocol for parturients on buprenorphine. 
The immediate impact of this project at the institution was a greater awareness of parturients on 
buprenorphine therapy. Another immediate impact was an increase in communication between 
the anesthesia department and maternal/fetal medicine practitioners when managing parturients 
on buprenorphine. This protocol could create a powerful impact over the long-term for 
parturients once fully implemented. A labor pain management protocol could improve 
maternal/fetal outcomes, decrease length of stay, and improve patient satisfaction. 
Conclusion 
 Limited data exists regarding peripartum pain management for the parturient on 
buprenorphine therapy. There is no universal guideline to aid anesthesia providers in the 
peripartum management of parturients undergoing MAT with buprenorphine.  As there are a lack 
of studies, most pain management recommendations for this population are made from case 
reports and provider opinion (Anderson, et al., 2017). As such, pain management strategies 
should be individualized, include multimodal analgesic options including oral, intravenous and 
neuraxial techniques, and be based on the collaborative efforts of the parturient, obstetrician, 
nurses, and anesthesia providers. The results of this project indicate that anesthesia providers and 
labor and delivery nurses at this facility were in favor of implementing a labor management 
protocol for parturients on buprenorphine. It can be concluded that the availability of such 
protocol may have a significant impact on the anesthesia providers, as well as the parturients in 
their care. 
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